Analysis of anti-asthmatic drug patents published in China between 2004 and 2013

References

• Baïz N, Annesi-Maesano I. Is the asthma epidemic still ascending? Clin Chest Med. 2012;33(3):419–429.
   PubMed Web of Science ®Google Scholar
• From the global strategy for asthma management and prevention. Global Initiative for Asthma (GINA); 2015 Available from: http://www.ginasthma.org/
   Google Scholar
• Wechsler ME. Getting control of uncontrolled asthma. Am J Med. 2014;127(11):1049–1059.
   PubMed Web of Science ®Google Scholar
• Zhang S, Zeng X, Wei J, et al. Analysis of patents on anti-allergic therapies issued in China from 1988 to 2008. Expert Opin Ther Pat. 2010;20(6):727–737.
   PubMed Web of Science ®Google Scholar
• Hao H, MA J, LI J, et al. Salmeterol preparation method. CN103420856A. 2013.
   Google Scholar
• Bessa J, Dalmases BP, Marquillas OF. New derivatives of 6-(4-phenylbutoxy) hexylamine and process for producing salmeterol. CN1189446C. 2005.
   Google Scholar
• Baker D, Bruce Mark. Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist. CN102724974A. 2012.
   Google Scholar
• Lohse O, Monnier S, Jordine G. Polymorphic crystal form of a indan-2-ylamino- hydroxyethyl -quinolinone maleate derivative as beta-adrenoceptor agonist. CN101511794A. 2009.
   Google Scholar
• KOV MERLI VALERIANO MANTOVANI. Levalbuterol hydrochloride polymorph A. CN1934068A. 2007.
   Google Scholar
• Chen Jianfeng, Liu Xiaolin, Xu Jing. Synthetic method for superfine sulfuric acid and salbutamol. CN1566076A. 2005.
   Google Scholar
• Adam H, Daniel B, Chen Yan, et al. Diamide compounds having muscarinic receptor antagonist and ss2 adrenergic receptor agonist activity. CN102405218A. 2012.
   Google Scholar
• Gross NJ. Anticholinergic agents in asthma and COPD. Eur J Pharmacol. 2006;533:36–39.
   PubMed Web of Science ®Google Scholar
• STEFFEN SPECK, GEORG PIEPER. MIC. Carbamic acid esters with anticholinergic activity. CN1717408A. 2006.
   Google Scholar
• Meissner P, Morschhae H. Novel anticholinergic agents that can be used as medicaments and method for the production thereof. CN1275962C. 2006.
   Google Scholar
• JI Y-H, Husfeld C, Lange C, et al. Quaternary ammonium diphenylmethyl compounds useful as muscarinic receptor antagonists. CN101616893A. 2009.
   Google Scholar
• Baker D, Bruce M, Crater G, et al. Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist. CN102724974A. 2012.
   Google Scholar
• Meade CJM. Combination of an anticholinergic and a steroid and its use to treat respiratory disorders by inhalation. CN1829520A. 2006.
   Google Scholar
• Pairet M, Meade M, John C, et al. Inhalation medicaments containing a novel anticholinesterase drug in conjunction with corticosteroids and betamimetic drugs. CN1688308A. 2005.
   Google Scholar
• Jingwang XU. Modulators of muscarinic receptors. CN101573121A. 2009.
   Google Scholar
• Bailey A, Mete A, Pairaudeau G, et al. New alkyl esters of cyclic amino alcohols with muscarinic m3 receptor antagonist activity, useful for treating e.g. chronic bronchial obstruction, asthma and overactive bladder. CN101490003A. 2009.
   Google Scholar
• Kristian N, Tolf B-R-R, Nicholas MK. Benzimidazolidinone derivatives as muscarinic agents. CN1561212A. 2005.
   Google Scholar
• LUETTKE ROLD BANHOLZER MANFRED; Method for producing anticholinergic agent substitute bromide. CN1244581C. 2006.
   Google Scholar
• LIU X. Method for preparing tiotropium bromide. CN101230063A. 2008.
   Google Scholar
• Collingwood SP. Combinations of glycopyrrolate and beta2 adrenoceptor agonists. CN1953745A. 2007.
   Google Scholar
• Xiangfu Y, Chongdong Z, Chensheng H, et al. Method for preparing 7-(2-hydroxypropyl) theophylline. CN102875554A. 2013.
   Google Scholar
• Xiangfu- Y, Chongdong Z, Chensheng H, et al. 8-chlorotheophylline preparation method. CN103360394A. 2013.
   Google Scholar
• Meissner R. 2-[1-phenyl-5-hydroxy or methoxy-4alpha-methyl-hexahydroclopenta[f]indazol-5-yl]ethyl phenyl derivatives as glucocorticoid receptor ligands. CN101528707A. 2009.
   Google Scholar
• Cheng H, Hu X, Kevin DJ, et al. Tricyclic compounds and their use as glucocorticoid receptor modulators. CN101616896A. 2009.
   Google Scholar
• Ding M, Hu X, Pei W, et al. Synthesis method for ciclesonide. CN101857627A. 2010.
   Google Scholar
• Kai D, Fengjie G. Method for synthesizing key intermediate of fluticasone propionate. CN103193844A. 2013.
   Google Scholar
• Weike S, Jiadi Z, Xiangjun S, et al. Synthesis method of key intermediate 17-beta-carboxylic acid derivative of fluticasone derivative. CN103073609A. 2013.
   Google Scholar
• Hegi W, Bandla J. Preparation of furoic acid momisone. CN1149222C. 2004.
   Google Scholar
• Dumitru C, Chan SMH, Turcanu V. Role of leukotriene receptor antagonists in the management of pediatric asthma: an update. Paediatr Drugs. 2012;14(5):317–330.
   PubMed Web of Science ®Google Scholar
• Alessandra B, Todd B, Zhidong C, et al. Oxadiazole inhibitors of leukotriene production. CN103261193A. 2013.
   Google Scholar
• Laliberte S, Grimm Erich L, Gareau Y, et al. Thiadiazole substituted coumarin derivatives and their use as leukotriene biosynthesis inhibitor, CN102627638A. 2012.
   Google Scholar
• Bhupathy M, Bergan J. Process for the preparation of leukotriene antagonists. CN101081834A. 2007.
   Google Scholar
• Yang L. Method for preparing zafirlukast important intermediate. CN101104601A. 2008.
   Google Scholar
• Wang T, Yu Q, Yuan B, et al. Preparation method of Montelukast Sodium intermediate. CN102442947A. 2012.
   Google Scholar
• Michael Woolven James AD. Phenyl-pyrazole derivatives as non-steroidal glucocoricoid receptor ligands. CN101501003A. 2009.
   Google Scholar
• Wang T, Yu Q, Yuan B, et al. Preparation method of Montelukast Sodium intermediate. CN102442947A. 2012.
   Google Scholar
• Choi-Sledeski YM, Nakyen C, Gregory Bernard P, et al. [4-(5-aminomethyl-2-fluoro-phenyl)-piperidin-1-yl]-[7-fluoro −1-(2-methoxy-ethyl)-4-trifluoromethoxy-1H-indol-3-yl]-methanone as an inhibitor of mast cell tryptase. CN102149705B. 2013.
   Google Scholar
• BEIHAN DU BOIS DAISY JOE KERTE. Piperazine derivatives for use as CCR-3 receptor antagonists in the treatment of asthma. CN1321115C. 2007.
   Google Scholar
• Ebel H, Frattini S, Giovannini R, et al. Cyclic pyrimidin-4-carboxamides as ccr2 receptor antagonists for treatment of inflammation, asthma and copd. CN102256 963A. 2011.
   Google Scholar
• Lebaut G, Manthew C, Kutetsche B N-substituted indole-3-acetaldehyde amide compound with anti-asthma, anti-amaphylactic and immunosupression/immunoregulation action. CN100488948C. 2009.
   Google Scholar
• Fanjing S. Traditional Chinese medicine composition for treating asthma. CN103463305A. 2013.
   Google Scholar
• Yanning LI. Medicament for treating infantile asthma. CN103463537A. 2013.
   Google Scholar
• Yipeng L. Traditional Chinese medicine composition for treating bronchial asthma and preparing method thereof. CN103417886A. 2013.
   Google Scholar
• Liying S, Dayong Y. Golden camellia flavonoid glycoside as well as preparation method and application thereof. CN103951723A. 2014.
   Google Scholar
• Sheng Y, Haibin L, Tingting L, et al. Application and preparation method of benzo alpha-pyrone compounds. CN103494806A. 2013.
   Google Scholar
• Olin JT, Wechsler ME. Asthma: pathogenesis and novel drugs for treatment. BMJ. 2014 24;349:g5517.
   PubMed Web of Science ®Google Scholar
• Sugihara N, Kanada S, Haida M, et al. 24-h bronchodilator efficacy of single doses of indacaterol in Japanese patients with asthma: a comparison with placebo and salmeterol. Respir Med. 2010;104(11):1629–1637.
   PubMed Web of Science ®Google Scholar
• Wenzel SE, Wang L, Pirozzi G. Dupilumab in persistent asthma. N Engl J Med. 2013;369:1276.
   PubMed Web of Science ®Google Scholar
• Gauvreau GM, Boulet LP, Cockcroft DW, et al. Antisense therapy against CCR3 and the common beta chain attenuates allergen-induced eosinophilic responses. Am J Respir Crit Care Med. 2008;177:952–958.
   PubMed Web of Science ®Google Scholar
• Beeh K-M, Kanniess F, Wagner F, et al. The novel TLR-9 agonist QbG10 shows clinical efficacy in persistent allergic asthma. J Allergy Clin Immunol. 2013;131:866–874.
   PubMed Web of Science ®Google Scholar
• Busse WW, Holgate S, Kerwin E, et al. Randomized, double-blind, placebo-controlled study of brodalumab, a human anti-IL-17 receptor monoclonal antibody, in moderate to severe asthma. Am J Respir Crit Care Med. 2013;188:1294–1302.
   PubMed Web of Science ®Google Scholar
• Parulekar AD, Boomer JS, Patterson BM, et al. A randomized controlled trial to evaluate inhibition of T-cell costimulation in allergen-induced airway inflammation. Am J Respir Crit Care Med. 2013;187(5):494–501.
   PubMed Web of Science ®Google Scholar
• Reber LL, Daubeuf F, Plantinga M, et al. A dissociated glucocorticoid receptor modulator reduces airway hyperresponsiveness and inflammation in a mouse model of asthma. J Immunol. 2012;188(7):3478–3487.
   PubMed Web of Science ®Google Scholar
• Xie H, Zhang H, Zhang S, et al. Analysis of antibiotic patents issued in China from 1992 to 2011. Expert Opin Ther Pat. 2012;22(10):1205–1232.
   PubMed Web of Science ®Google Scholar